The FDA approved Gardasil 9, a new drug that promises to protects from Human Papillomavirus (HPV) diseases such as cervical cancer, vulvar cancer, anal cancer and vaginal cancer. Gardasil 9 is in the form of a vaccine.
Gardasil
9 is a vaccine that can be used by women between the ages of 9 and 26
and men between the ages of 9 and 15. The vaccine believes to treat nine types of HPV viruses.
Karen Midthun,
M.D., director of the FDA’s Center for Biologics Evaluation and
Research said, “Vaccination is a critical public health measure for
lowering the risk of most cervical, genital and anal cancers caused by
HPV.”
“The approval of Gardasil 9 provides broader protection against HPV-related cancers.”
For Gardasil 9, a controlled clinical study was
conducted in the U.S. and internationally in approximately 14,000
females ages 16 through 26 who tested negative for vaccine HPV types at
the start of the study. The result of the study showed that Gardasil 9
is 97 percent effective in preventing cervical cancer and vaginal
cancer.
Gardasil 9 is administered in three shots. According to
U.S. Food and Drug Administration, the vaccine is effective in
protecting people who are vaccinated prior to becoming infected.
Based on an evaluation of approximately 13,000 males and females who had Gardasil 9 injection, the common side effects were injection site pain, swelling, redness, and headaches.
No comments:
Post a Comment